Search Results - "Cruz, CJ"
-
1
Proton MR spectroscopic imaging of the striatum in Parkinson's disease
Published in Magnetic resonance imaging (1997)“…Assess the feasibility of proton MR spectroscopic imaging ( 1H-MRSI) of the striatum (putamen and caudate nucleus) in patients with Parkinson's disease and…”
Get full text
Journal Article -
2
Large-bowel obstruction resulting from traumatic diaphragmatic hernia: imaging findings in four cases
Published in American journal of roentgenology (1976) (01-04-1994)“…Large-bowel obstruction is most often due to primary carcinoma, diverticulitis, or volvulus. In populations of patients in which trauma is prevalent, however,…”
Get full text
Journal Article -
3
Striatal axons to the globus pallidus, entopeduncular nucleus and substantia nigra come mainly from separate cell populations in cat
Published in Neuroscience (01-09-1986)“…The extent to which individual striatal neurons send collaterals to the globus pallidus, entopeduncular nucleus and substantia nigra in the cat brain was…”
Get more information
Journal Article -
4
Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra
Published in Neuroscience (1989)“…Striatal dopamine was depleted in adult rats by unilateral infusion of 6-hydroxydopamine near the dopamine neurons of the pars compacta of the substantia…”
Get more information
Journal Article -
5
Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra
Published in Brain research (02-08-1988)“…Chronic blockade of the dopamine (DA) D2 receptor by repeated systemic administration of the butyrophenone neuroleptic, haloperidol (HAL), is known to lead to…”
Get more information
Journal Article -
6
GABA-mimetic drugs enhance apomorphine-induced contralateral turning in rats with unilateral nigrostriatal dopamine denervation: implications for the therapy of Parkinson's disease
Published in Annals of neurology (01-01-1987)“…The underlying mechanisms responsible for advanced Parkinson's disease's becoming refractory to dopamimetic therapies are unclear. Postmortem brain studies…”
Get more information
Journal Article